PET/MRI shows inflammation link to mitral valve prolapse
June 1, 2020 -- Researchers using a hybrid PET/MRI scanner detected a link between degenerative mitral valve prolapse and F-18 FDG uptake, a surrogate for myocardial inflammation and/or ischemia. The results, published online May 27 in JAMA Cardiology, apply to asymptomatic patients as well, suggesting an ongoing subclinical disease process. Read More
FDA approves Avid's flortaucipir PET agent for tau imaging
May 28, 2020 -- In what the agency called a regulatory first, the U.S. Food and Drug Administration (FDA) has approved the radiopharmaceutical flortaucipir F-18 for imaging tau pathology on PET scans. The agent was developed by Eli Lilly subsidiary Avid Radiopharmaceuticals and will be marketed as Tauvid. Read More